LakeShore Biopharma Co., Ltd Cash Flow Quality Index
LakeShore Biopharma Co., Ltd cash flow quality index. LakeShore Biopharma Co., Ltd (LSB) has a Cash Flow Quality Index of -0.06x as of June 2022. Operating cash flow of $-693.96K is below net income of $11.52 Million, suggesting accrual-heavy earnings not yet converted to cash. See LakeShore Biopharma Co., Ltd (LSB) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
LakeShore Biopharma Co., Ltd Cash Flow Quality Index by Year (None–None)
LakeShore Biopharma Co., Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for LakeShore Biopharma Co., Ltd. For the full cash flow conversion analysis, see cash flow conversion of LakeShore Biopharma Co., Ltd.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|